English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 120 | Tables: 124 | Medical Devices & Consumables
The global Combination Vaccines for Children market was valued at US$ 6420 million in 2025 and is anticipated to reach US$ 10731 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Combination Vaccines for Children competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2025, global Combination Vaccines for Children production reached approximately 535 M Doses, with an average global market price of around 12 US$/dose.
Combination Vaccines for Children are specialized immunization products designed for infants and children, formulated by combining antigens of multiple pathogenic microorganisms (such as bacteria, viruses) into a single vaccine. These vaccines are scientifically developed to trigger a protective immune response against multiple diseases simultaneously, reducing the number of injections children need to receive during the critical immunization period (0-6 years old). They strictly comply with national and international immunization standards, ensuring safety, efficacy, and compatibility of the combined antigens, and cover common childhood diseases such as diphtheria, tetanus, pertussis, polio, hepatitis B, and Haemophilus influenzae type b (Hib). As a core part of childhood immunization programs, they not only improve vaccination compliance but also reduce the burden on children, parents, and medical institutions, playing a vital role in preventing childhood infectious diseases.
The market demand for Combination Vaccines for Children maintains steady and rapid growth, driven by the global emphasis on childhood immunization, the popularization of national immunization programs, and the increasing demand for convenient, safe, and efficient vaccination solutions, creating substantial business opportunities. Demand is primarily fueled by government-led immunization programs, private medical institutions, and parents’ growing awareness of child health, with emerging markets showing stronger growth potential due to improving medical infrastructure and rising per capita income. Business opportunities lie in R&D of multi-valent combination vaccines covering more childhood diseases, optimizing formulations to improve safety and efficacy (such as reducing side effects), expanding production capacity to meet growing market demand, and cooperating with governments and international health organizations to participate in immunization programs, especially tapping into the untapped potential of emerging markets with insufficient vaccine coverage.
This report delivers a comprehensive overview of the global Combination Vaccines for Children market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Combination Vaccines for Children. The Combination Vaccines for Children market size, estimates, and forecasts are provided in terms of sales volume (M Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Combination Vaccines for Children market comprehensively. Regional market sizes by Valence, by Application, by Pathogen Type, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Combination Vaccines for Children manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Valence, by Application, and by region.
Market Segmentation
By Company
GlaxoSmithKline (GSK)
Merck
KM Biologics
Walvax Biotechnology
Biokangtai
Sinovac
Sanofi
Serum Institute of India
Biological E.
Panacea Biotec
Bharat Biotech
LG Chem
PT Bio Farma
Segment by Valence
Bivalent Type
Trivalent Type
Multivalent Type (≥4 Valents)
Segment by Pathogen Type
Bacterial-Viral Combined
Bacterial-Bacterial Combined
Viral-Viral Combined
Segment by Administration Route
Intramuscular Injection
Subcutaneous Injection
Oral Combined
by Application
Routine Childhood Immunization
Public Health
Private Medical
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Valence, by Application, by Pathogen Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Combination Vaccines for Children manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Combination Vaccines for Children sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Valence, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Combination Vaccines for Children Market Overview
1.1 Product Definition
1.2 Combination Vaccines for Children by Valence
1.2.1 Global Combination Vaccines for Children Market Value by Valence: 2025 vs 2032
1.2.2 Bivalent Type
1.2.3 Trivalent Type
1.2.4 Multivalent Type (≥4 Valents)
1.3 Combination Vaccines for Children by Pathogen Type
1.3.1 Global Combination Vaccines for Children Market Value by Pathogen Type: 2025 vs 2032
1.3.2 Bacterial-Viral Combined
1.3.3 Bacterial-Bacterial Combined
1.3.4 Viral-Viral Combined
1.4 Combination Vaccines for Children by Administration Route
1.4.1 Global Combination Vaccines for Children Market Value by Administration Route: 2025 vs 2032
1.4.2 Intramuscular Injection
1.4.3 Subcutaneous Injection
1.4.4 Oral Combined
1.5 Combination Vaccines for Children by Application
1.5.1 Global Combination Vaccines for Children Market Value by Application: 2025 vs 2032
1.5.2 Routine Childhood Immunization
1.5.3 Public Health
1.5.4 Private Medical
1.6 Global Combination Vaccines for Children Market Size Estimates and Forecasts
1.6.1 Global Combination Vaccines for Children Revenue 2021–2032
1.6.2 Global Combination Vaccines for Children Sales 2021–2032
1.6.3 Global Combination Vaccines for Children Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Combination Vaccines for Children Market Competition by Manufacturers
2.1 Global Combination Vaccines for Children Sales Market Share by Manufacturers (2021–2026)
2.2 Global Combination Vaccines for Children Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Combination Vaccines for Children Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Combination Vaccines for Children, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Combination Vaccines for Children, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Combination Vaccines for Children, Product Types and Applications
2.7 Global Key Manufacturers of Combination Vaccines for Children, Date of Entry into the Industry
2.8 Global Combination Vaccines for Children Market Competitive Situation and Trends
2.8.1 Global Combination Vaccines for Children Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Combination Vaccines for Children Players Market Share by Revenue
2.8.3 Global Combination Vaccines for Children Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Combination Vaccines for Children Market Scenario by Region
3.1 Global Combination Vaccines for Children Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Combination Vaccines for Children Sales by Region: 2021–2032
3.2.1 Global Combination Vaccines for Children Sales by Region: 2021–2026
3.2.2 Global Combination Vaccines for Children Sales by Region: 2027–2032
3.3 Global Combination Vaccines for Children Revenue by Region: 2021–2032
3.3.1 Global Combination Vaccines for Children Revenue by Region: 2021–2026
3.3.2 Global Combination Vaccines for Children Revenue by Region: 2027–2032
3.4 North America Combination Vaccines for Children Market Facts & Figures by Country
3.4.1 North America Combination Vaccines for Children Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Combination Vaccines for Children Sales by Country (2021–2032)
3.4.3 North America Combination Vaccines for Children Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Combination Vaccines for Children Market Facts & Figures by Country
3.5.1 Europe Combination Vaccines for Children Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Combination Vaccines for Children Sales by Country (2021–2032)
3.5.3 Europe Combination Vaccines for Children Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Combination Vaccines for Children Market Facts & Figures by Region
3.6.1 Asia Pacific Combination Vaccines for Children Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Combination Vaccines for Children Sales by Region (2021–2032)
3.6.3 Asia Pacific Combination Vaccines for Children Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Combination Vaccines for Children Market Facts & Figures by Country
3.7.1 Latin America Combination Vaccines for Children Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Combination Vaccines for Children Sales by Country (2021–2032)
3.7.3 Latin America Combination Vaccines for Children Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Combination Vaccines for Children Market Facts & Figures by Country
3.8.1 Middle East and Africa Combination Vaccines for Children Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Combination Vaccines for Children Sales by Country (2021–2032)
3.8.3 Middle East and Africa Combination Vaccines for Children Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Valence
4.1 Global Combination Vaccines for Children Sales by Valence (2021–2032)
4.1.1 Global Combination Vaccines for Children Sales by Valence (2021–2026)
4.1.2 Global Combination Vaccines for Children Sales by Valence (2027–2032)
4.1.3 Global Combination Vaccines for Children Sales Market Share by Valence (2021–2032)
4.2 Global Combination Vaccines for Children Revenue by Valence (2021–2032)
4.2.1 Global Combination Vaccines for Children Revenue by Valence (2021–2026)
4.2.2 Global Combination Vaccines for Children Revenue by Valence (2027–2032)
4.2.3 Global Combination Vaccines for Children Revenue Market Share by Valence (2021–2032)
4.3 Global Combination Vaccines for Children Price by Valence (2021–2032)
5 Segment by Application
5.1 Global Combination Vaccines for Children Sales by Application (2021–2032)
5.1.1 Global Combination Vaccines for Children Sales by Application (2021–2026)
5.1.2 Global Combination Vaccines for Children Sales by Application (2027–2032)
5.1.3 Global Combination Vaccines for Children Sales Market Share by Application (2021–2032)
5.2 Global Combination Vaccines for Children Revenue by Application (2021–2032)
5.2.1 Global Combination Vaccines for Children Revenue by Application (2021–2026)
5.2.2 Global Combination Vaccines for Children Revenue by Application (2027–2032)
5.2.3 Global Combination Vaccines for Children Revenue Market Share by Application (2021–2032)
5.3 Global Combination Vaccines for Children Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GlaxoSmithKline (GSK)
6.1.1 GlaxoSmithKline (GSK) Company Information
6.1.2 GlaxoSmithKline (GSK) Description and Business Overview
6.1.3 GlaxoSmithKline (GSK) Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GlaxoSmithKline (GSK) Combination Vaccines for Children Product Portfolio
6.1.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Combination Vaccines for Children Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 KM Biologics
6.3.1 KM Biologics Company Information
6.3.2 KM Biologics Description and Business Overview
6.3.3 KM Biologics Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 KM Biologics Combination Vaccines for Children Product Portfolio
6.3.5 KM Biologics Recent Developments/Updates
6.4 Walvax Biotechnology
6.4.1 Walvax Biotechnology Company Information
6.4.2 Walvax Biotechnology Description and Business Overview
6.4.3 Walvax Biotechnology Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Walvax Biotechnology Combination Vaccines for Children Product Portfolio
6.4.5 Walvax Biotechnology Recent Developments/Updates
6.5 Biokangtai
6.5.1 Biokangtai Company Information
6.5.2 Biokangtai Description and Business Overview
6.5.3 Biokangtai Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Biokangtai Combination Vaccines for Children Product Portfolio
6.5.5 Biokangtai Recent Developments/Updates
6.6 Sinovac
6.6.1 Sinovac Company Information
6.6.2 Sinovac Description and Business Overview
6.6.3 Sinovac Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sinovac Combination Vaccines for Children Product Portfolio
6.6.5 Sinovac Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sanofi Combination Vaccines for Children Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Serum Institute of India
6.8.1 Serum Institute of India Company Information
6.8.2 Serum Institute of India Description and Business Overview
6.8.3 Serum Institute of India Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Serum Institute of India Combination Vaccines for Children Product Portfolio
6.8.5 Serum Institute of India Recent Developments/Updates
6.9 Biological E.
6.9.1 Biological E. Company Information
6.9.2 Biological E. Description and Business Overview
6.9.3 Biological E. Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Biological E. Combination Vaccines for Children Product Portfolio
6.9.5 Biological E. Recent Developments/Updates
6.10 Panacea Biotec
6.10.1 Panacea Biotec Company Information
6.10.2 Panacea Biotec Description and Business Overview
6.10.3 Panacea Biotec Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Panacea Biotec Combination Vaccines for Children Product Portfolio
6.10.5 Panacea Biotec Recent Developments/Updates
6.11 Bharat Biotech
6.11.1 Bharat Biotech Company Information
6.11.2 Bharat Biotech Description and Business Overview
6.11.3 Bharat Biotech Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Bharat Biotech Combination Vaccines for Children Product Portfolio
6.11.5 Bharat Biotech Recent Developments/Updates
6.12 LG Chem
6.12.1 LG Chem Company Information
6.12.2 LG Chem Description and Business Overview
6.12.3 LG Chem Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 LG Chem Combination Vaccines for Children Product Portfolio
6.12.5 LG Chem Recent Developments/Updates
6.13 PT Bio Farma
6.13.1 PT Bio Farma Company Information
6.13.2 PT Bio Farma Description and Business Overview
6.13.3 PT Bio Farma Combination Vaccines for Children Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 PT Bio Farma Combination Vaccines for Children Product Portfolio
6.13.5 PT Bio Farma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Combination Vaccines for Children Industry Chain Analysis
7.2 Combination Vaccines for Children Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Combination Vaccines for Children Production Mode & Process Analysis
7.4 Combination Vaccines for Children Sales and Marketing
7.4.1 Combination Vaccines for Children Sales Channels
7.4.2 Combination Vaccines for Children Distributors
7.5 Combination Vaccines for Children Customer Analysis
8 Combination Vaccines for Children Market Dynamics
8.1 Combination Vaccines for Children Industry Trends
8.2 Combination Vaccines for Children Market Drivers
8.3 Combination Vaccines for Children Market Challenges
8.4 Combination Vaccines for Children Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Combination Vaccines for Children Market Value by Valence (US$ Million), 2025 vs 2032
Table 2. Global Combination Vaccines for Children Market Value by Pathogen Type (US$ Million), 2025 vs 2032
Table 3. Global Combination Vaccines for Children Market Value by Administration Route (US$ Million), 2025 vs 2032
Table 4. Global Combination Vaccines for Children Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Combination Vaccines for Children Market Competitive Situation by Manufacturers in 2025
Table 6. Global Combination Vaccines for Children Sales (M Doses) of Key Manufacturers (2021–2026)
Table 7. Global Combination Vaccines for Children Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Combination Vaccines for Children Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Combination Vaccines for Children Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Combination Vaccines for Children Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Combination Vaccines for Children, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Combination Vaccines for Children, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Combination Vaccines for Children, Product Types and Applications
Table 14. Global Key Manufacturers of Combination Vaccines for Children, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Combination Vaccines for Children Companies by Tier (Tier 1, Tier 2, Tier 3), based on Combination Vaccines for Children Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Combination Vaccines for Children Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Combination Vaccines for Children Sales by Region (M Doses), 2021–2026
Table 20. Global Combination Vaccines for Children Sales Market Share by Region (2021–2026)
Table 21. Global Combination Vaccines for Children Sales by Region (M Doses), 2027–2032
Table 22. Global Combination Vaccines for Children Sales Market Share by Region (2027–2032)
Table 23. Global Combination Vaccines for Children Revenue by Region (US$ Million), 2021–2026
Table 24. Global Combination Vaccines for Children Revenue Market Share by Region (2021–2026)
Table 25. Global Combination Vaccines for Children Revenue by Region (US$ Million), 2027–2032
Table 26. Global Combination Vaccines for Children Revenue Market Share by Region (2027–2032)
Table 27. North America Combination Vaccines for Children Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Combination Vaccines for Children Sales by Country (M Doses), 2021–2026
Table 29. North America Combination Vaccines for Children Sales by Country (M Doses), 2027–2032
Table 30. North America Combination Vaccines for Children Revenue by Country (US$ Million), 2021–2026
Table 31. North America Combination Vaccines for Children Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Combination Vaccines for Children Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Combination Vaccines for Children Sales by Country (M Doses), 2021–2026
Table 34. Europe Combination Vaccines for Children Sales by Country (M Doses), 2027–2032
Table 35. Europe Combination Vaccines for Children Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Combination Vaccines for Children Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Combination Vaccines for Children Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Combination Vaccines for Children Sales by Region (M Doses), 2021–2026
Table 39. Asia Pacific Combination Vaccines for Children Sales by Region (M Doses), 2027–2032
Table 40. Asia Pacific Combination Vaccines for Children Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Combination Vaccines for Children Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Combination Vaccines for Children Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Combination Vaccines for Children Sales by Country (M Doses), 2021–2026
Table 44. Latin America Combination Vaccines for Children Sales by Country (M Doses), 2027–2032
Table 45. Latin America Combination Vaccines for Children Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Combination Vaccines for Children Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Combination Vaccines for Children Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Combination Vaccines for Children Sales by Country (M Doses), 2021–2026
Table 49. Middle East and Africa Combination Vaccines for Children Sales by Country (M Doses), 2027–2032
Table 50. Middle East and Africa Combination Vaccines for Children Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Combination Vaccines for Children Revenue by Country (US$ Million), 2027–2032
Table 52. Global Combination Vaccines for Children Sales (M Doses) by Valence (2021–2026)
Table 53. Global Combination Vaccines for Children Sales (M Doses) by Valence (2027–2032)
Table 54. Global Combination Vaccines for Children Sales Market Share by Valence (2021–2026)
Table 55. Global Combination Vaccines for Children Sales Market Share by Valence (2027–2032)
Table 56. Global Combination Vaccines for Children Revenue (US$ Million) by Valence (2021–2026)
Table 57. Global Combination Vaccines for Children Revenue (US$ Million) by Valence (2027–2032)
Table 58. Global Combination Vaccines for Children Revenue Market Share by Valence (2021–2026)
Table 59. Global Combination Vaccines for Children Revenue Market Share by Valence (2027–2032)
Table 60. Global Combination Vaccines for Children Price (US$/Dose) by Valence (2021–2026)
Table 61. Global Combination Vaccines for Children Price (US$/Dose) by Valence (2027–2032)
Table 62. Global Combination Vaccines for Children Sales (M Doses) by Application (2021–2026)
Table 63. Global Combination Vaccines for Children Sales (M Doses) by Application (2027–2032)
Table 64. Global Combination Vaccines for Children Sales Market Share by Application (2021–2026)
Table 65. Global Combination Vaccines for Children Sales Market Share by Application (2027–2032)
Table 66. Global Combination Vaccines for Children Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Combination Vaccines for Children Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Combination Vaccines for Children Revenue Market Share by Application (2021–2026)
Table 69. Global Combination Vaccines for Children Revenue Market Share by Application (2027–2032)
Table 70. Global Combination Vaccines for Children Price (US$/Dose) by Application (2021–2026)
Table 71. Global Combination Vaccines for Children Price (US$/Dose) by Application (2027–2032)
Table 72. GlaxoSmithKline (GSK) Company Information
Table 73. GlaxoSmithKline (GSK) Description and Business Overview
Table 74. GlaxoSmithKline (GSK) Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 75. GlaxoSmithKline (GSK) Combination Vaccines for Children Product
Table 76. GlaxoSmithKline (GSK) Recent Developments/Updates
Table 77. Merck Company Information
Table 78. Merck Description and Business Overview
Table 79. Merck Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 80. Merck Combination Vaccines for Children Product
Table 81. Merck Recent Developments/Updates
Table 82. KM Biologics Company Information
Table 83. KM Biologics Description and Business Overview
Table 84. KM Biologics Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 85. KM Biologics Combination Vaccines for Children Product
Table 86. KM Biologics Recent Developments/Updates
Table 87. Walvax Biotechnology Company Information
Table 88. Walvax Biotechnology Description and Business Overview
Table 89. Walvax Biotechnology Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 90. Walvax Biotechnology Combination Vaccines for Children Product
Table 91. Walvax Biotechnology Recent Developments/Updates
Table 92. Biokangtai Company Information
Table 93. Biokangtai Description and Business Overview
Table 94. Biokangtai Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 95. Biokangtai Combination Vaccines for Children Product
Table 96. Biokangtai Recent Developments/Updates
Table 97. Sinovac Company Information
Table 98. Sinovac Description and Business Overview
Table 99. Sinovac Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 100. Sinovac Combination Vaccines for Children Product
Table 101. Sinovac Recent Developments/Updates
Table 102. Sanofi Company Information
Table 103. Sanofi Description and Business Overview
Table 104. Sanofi Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 105. Sanofi Combination Vaccines for Children Product
Table 106. Sanofi Recent Developments/Updates
Table 107. Serum Institute of India Company Information
Table 108. Serum Institute of India Description and Business Overview
Table 109. Serum Institute of India Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 110. Serum Institute of India Combination Vaccines for Children Product
Table 111. Serum Institute of India Recent Developments/Updates
Table 112. Biological E. Company Information
Table 113. Biological E. Description and Business Overview
Table 114. Biological E. Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 115. Biological E. Combination Vaccines for Children Product
Table 116. Biological E. Recent Developments/Updates
Table 117. Panacea Biotec Company Information
Table 118. Panacea Biotec Description and Business Overview
Table 119. Panacea Biotec Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 120. Panacea Biotec Combination Vaccines for Children Product
Table 121. Panacea Biotec Recent Developments/Updates
Table 122. Bharat Biotech Company Information
Table 123. Bharat Biotech Description and Business Overview
Table 124. Bharat Biotech Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 125. Bharat Biotech Combination Vaccines for Children Product
Table 126. Bharat Biotech Recent Developments/Updates
Table 127. LG Chem Company Information
Table 128. LG Chem Description and Business Overview
Table 129. LG Chem Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 130. LG Chem Combination Vaccines for Children Product
Table 131. LG Chem Recent Developments/Updates
Table 132. PT Bio Farma Company Information
Table 133. PT Bio Farma Description and Business Overview
Table 134. PT Bio Farma Combination Vaccines for Children Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 135. PT Bio Farma Combination Vaccines for Children Product
Table 136. PT Bio Farma Recent Developments/Updates
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Combination Vaccines for Children Distributors List
Table 140. Combination Vaccines for Children Customers List
Table 141. Combination Vaccines for Children Market Trends
Table 142. Combination Vaccines for Children Market Drivers
Table 143. Combination Vaccines for Children Market Challenges
Table 144. Combination Vaccines for Children Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Authors List of This Report
List of Figures
Figure 1. Product Picture of Combination Vaccines for Children
Figure 2. Global Combination Vaccines for Children Market Value by Valence (US$ Million), 2021–2032
Figure 3. Global Combination Vaccines for Children Market Share by Valence: 2025 & 2032
Figure 4. Bivalent Type Product Picture
Figure 5. Trivalent Type Product Picture
Figure 6. Multivalent Type (≥4 Valents) Product Picture
Figure 7. Global Combination Vaccines for Children Market Value by Pathogen Type (US$ Million), 2021–2032
Figure 8. Global Combination Vaccines for Children Market Share by Pathogen Type: 2025 vs 2032
Figure 9. Bacterial-Viral Combined Product Picture
Figure 10. Bacterial-Bacterial Combined Product Picture
Figure 11. Viral-Viral Combined Product Picture
Figure 12. Global Combination Vaccines for Children Market Value by Administration Route (US$ Million), 2021–2032
Figure 13. Global Combination Vaccines for Children Market Share by Administration Route: 2025 vs 2032
Figure 14. Intramuscular Injection Product Picture
Figure 15. Subcutaneous Injection Product Picture
Figure 16. Oral Combined Product Picture
Figure 17. Global Combination Vaccines for Children Market Value by Application (US$ Million), 2021–2032
Figure 18. Global Combination Vaccines for Children Market Share by Application: 2025 & 2032
Figure 19. Routine Childhood Immunization
Figure 20. Public Health
Figure 21. Private Medical
Figure 22. Global Combination Vaccines for Children Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Combination Vaccines for Children Market Size (US$ Million), 2021–2032
Figure 24. Global Combination Vaccines for Children Sales (M Doses), 2021–2032
Figure 25. Global Combination Vaccines for Children Average Price (US$/Dose), 2021–2032
Figure 26. Combination Vaccines for Children Report Years Considered
Figure 27. Combination Vaccines for Children Sales Share by Manufacturers in 2025
Figure 28. Global Combination Vaccines for Children Revenue Share by Manufacturers in 2025
Figure 29. Top 5 and Top 10 Global Combination Vaccines for Children Players: Market Share by Revenue in Combination Vaccines for Children in 2025
Figure 30. Combination Vaccines for Children Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 31. Global Combination Vaccines for Children Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 32. North America Combination Vaccines for Children Sales Market Share by Country (2021–2032)
Figure 33. North America Combination Vaccines for Children Revenue Market Share by Country (2021–2032)
Figure 34. United States Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Canada Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Europe Combination Vaccines for Children Sales Market Share by Country (2021–2032)
Figure 37. Europe Combination Vaccines for Children Revenue Market Share by Country (2021–2032)
Figure 38. Germany Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. France Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. U.K. Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Italy Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Russia Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific Combination Vaccines for Children Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific Combination Vaccines for Children Revenue Market Share by Region (2021–2032)
Figure 45. China Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. China Taiwan Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Southeast Asia Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Latin America Combination Vaccines for Children Sales Market Share by Country (2021–2032)
Figure 53. Latin America Combination Vaccines for Children Revenue Market Share by Country (2021–2032)
Figure 54. Mexico Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Brazil Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Argentina Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Colombia Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Combination Vaccines for Children Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Combination Vaccines for Children Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. UAE Combination Vaccines for Children Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Combination Vaccines for Children by Valence (2021–2032)
Figure 64. Global Revenue Market Share of Combination Vaccines for Children by Valence (2021–2032)
Figure 65. Global Combination Vaccines for Children Price (US$/Dose) by Valence (2021–2032)
Figure 66. Global Sales Market Share of Combination Vaccines for Children by Application (2021–2032)
Figure 67. Global Revenue Market Share of Combination Vaccines for Children by Application (2021–2032)
Figure 68. Global Combination Vaccines for Children Price (US$/Dose) by Application (2021–2032)
Figure 69. Combination Vaccines for Children Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
